Presentation ACC 2026 Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis Presenter: Nicholas Marston March 30, 2026
Presentation ACC 2026 IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial Presenter: Shao-Liang Chen March 30, 2026
Presentation ACC 2026 Controlled trial of High-risk coronary Intervention with Percutaneous left ventricular unloading (CHIP-BCIS3) Presenter: Divaka Perera March 29, 2026
Presentation ACC 2026 Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina – (ORBITA-CTO) A randomized, placebo-controlled trial Presenter: Sarosh Khan March 29, 2026
Presentation ACC 2026 SPIRonolactone In the Treatment of Heart Failure Presenter: Frank Edelmann March 29, 2026
Presentation ACC 2026 Deferral of PCI in Patients Undergoing TAVI (PRO-TAVI): an Investigator-Initiated, Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial Presenter: Michiel Voskuil March 29, 2026
Presentation ACC 2026 Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment: The ALL-RISE Randomized Trial Presenter: Ajay J. Kirtane March 29, 2026
Presentation ACC 2026 Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR guided revascularization: the FAST III Trial Presenter: Joost Daemen March 29, 2026
Presentation ACC 2026 The STEMI Door to Unload Trial (STEMI-DTU) Presenter: Gregg Stone March 28, 2026
Presentation ACC 2026 Intensive LDL cholesterol targeting in atherosclerotic cardiovascular disease: The Ez-PAVE randomized clinical trial Presenter: Byeong-Keuk Kim March 28, 2026
Presentation THT 2026 Physiology and Hemodynamics of Left Atrial to Coronary Sinus Shunting: Potential Implications for Clinical Effectiveness Presenter: Ryan J. Tedford March 04, 2026
Presentation THT 2026 Response to left atrial to coronary sinus shunting in patients with heart failure and atrial fibrilllation Presenter: JoAnn Lindenfeld March 03, 2026
Presentation THT 2026 Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results Presenter: Benjamin Hibbert March 03, 2026
Presentation THT 2026 Adjunctive Supersaturated Oxygen Therapy Following PCI in Acute Coronary Syndrome With Cardiogenic Shock: A Randomized Study Presenter: Sanchit Kundal March 02, 2026
Presentation THT 2026 Prospective Validation of the STOPSHOCK Score for Early Cardiogenic Shock Prediction in Acute Coronary Syndrome: A Real-World Perspective Presenter: Allan Böhm March 02, 2026
Presentation THT Abstracts 2026 Hemodynamic and Functional Impact of Coronary Sinus Reducer Versus Enhanced External Counterpulsation in Chronic Ischemic Heart Failure Presenter: Nayana Bhandari March 02, 2026
Presentation CTO 2026 Safety and Feasibility of the Supira System in High Risk Percutaneous Coronary Interventions: 1-Year Single Center Results From the US SUPPORT I EFS Presenter: Tai Pham February 14, 2026
Presentation CTO 2026 Preclinical Evaluation of the Novel Tigerheart Coronary CTO-Crossing Catheter: Readiness for Future Clinical Investigation Presenter: Kevin J. Croce February 14, 2026
Presentation CTO 2026 The Morphological and Mechanistic Impact of an Investment Procedure in Coronary Chronic Total Occlusions Presenter: Anja Oksnes February 14, 2026
Presentation CTO 2026 Left Anterior Descending Chronic Total Occlusion Percutaneous Coronary Intervention: Investment Is the Key Presenter: Judit Karacsonyi February 14, 2026